Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 4, 2007, Pages 647-653

  Périé, Sophie ^a   Hugentobler, Alexis ^a   Susini, Bertrand ^a   Balogova, Sona ^a   Grahek, Dany ^a   Kerrou, Khaldoun ^a   Montravers, Françoise ^a   Chater, Pierre El ^a   St Guily, Jean Lacau ^a   Talbot, Jean Noël ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; DECISION MAKING; DIAGNOSTIC VALUE; ENDOSCOPY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DECISION MAKING; ENDOSCOPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34548825639     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.05.063     Document Type: Article

References (20)

1. Cheon G.J., Chung J.K., So Y., et al. Diagnostic accuracy of F-18 FDG-PET in the assessment of post therapeutic recurrence of head and neck cancer. Clin Positron Imaging 2 (1999) 197-204 (Grade 2).
2. Farber L.A., Benard F., Machtay M., et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 109 (1999) 970-975 (Grade 3).
3. Hanasono M.M., Kunda L.D., Segall G.M., et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 109 (1999) 880-885 (Grade 3).
4. Lapela M., Eigtved A., Jyrkkio S., et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36 (2000) 858-867 (Grade 2).
5. Lonneux M., Lawson G., Bausart R., et al. Positron emission tomography with fluorodeoxyglucose for suspected "head and neck" tumour recurrence in the symptomatic patients. Laryngoscope 110 (2000) 1493-1497 (Grade 2).
6. Greven K.M., Williams III D.W., McGuirt Sr. W.F., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946 (Grade 2).
7. Terhaard C.H., Bongers V., van Rijk P.P., et al. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 23 (2001) 933-941 (Grade 2).
8. Greven K.M., Williams III D.W., Keyes Jr. J.W., et al. Can positron emission tomography distinguish tumor recurrence from irradiation sequalae in patients treated for larynx cancer?. Cancer J Sci Am 3 (1997) 353-357 (Grade 2).
9. Stokkel M.P., Terhaard C.H., Hordijk G.J., et al. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 26 (1999) 767-773 (Grade 2).
10. Goerres G.W., Schmid D.T., Bandhauer F., et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 105-109 (Grade 2).
11. Lecanu J.B., Monceaux G., Perie S., et al. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy. Laryngoscope 110 (2000) 412-416 (Grade 3).
12. Dufour X., Hans S., De Mones E., et al. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 130 (2004) 1092-1099 (Grade 3).
13. Goodwin Jr. W.J. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?. Laryngoscope 110 (2000) 1-18 (Grade 1).
14. Dietz A., Rudat V., Harms W., et al. Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy. HNO 52 (2004) 38-44 (Grade 2).
15. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690 (Grade 1).
16. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098 (Grade 1).
17. Dhooge I.J., De Vos M., and Van Cauwenberge P.B. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 108 (1998) 250-256 (Grade 2).
18. Schöder H., Yeung H.W.D., Gonen M., et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231 (2004) 65-72 (Grade 3).
19. Branstetter B.F., Blodgett T.M., Zimmer L.A., et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology 235 (2005) 580-586 (Grade 2).
20. Lowe V.J., Boyd J.H., Dunphy F.R., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658 (Grade 2).